Biotech · Private company
Orphalan
Track this companyFree. Adds Orphalan to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- D-PenicillaminePhase 3 · Wilson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Penicillamine (D1-W12)Phase 3 · Wilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Penicillamine (W12-W60)Phase 3 · Wilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TETA 4HCL (60-<W108)Phase 3 · Wilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TETA 4HCL (W12-60)Phase 3 · Wilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TETA 4HCl formulationPhase 3 · Wilson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NCC-Sp AssayWilson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.PHASE3 · RECRUITING · started Sep 3, 2026ClinicalTrials.gov NCT07465718 · fetched Nov 12, 2026
- Real World Evidence Study in Subjects With Wilson's DiseaseCOMPLETED · started Jun 28, 2023ClinicalTrials.gov NCT05783687 · fetched Nov 12, 2026
- Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's DiseasePHASE3 · COMPLETED · started Sep 3, 2018ClinicalTrials.gov NCT03539952 · fetched Nov 12, 2026